Evidence map›Paper›PMID 33875251›Full record

ArticleSurgery2021

Corrigendum to: Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment [Surgery. 2020 Jan;167(1):189-196. doi: 10.1016/j.surg.2019.05.092. Epub 2019 Oct 16.PMID: 31629542].

R Guenter, T Aweda, D M Carmona Matos, S Jang, J Whitt, Y Q Cheng, X M Liu, H Chen, S E Lapi, R Jaskula-Sztul

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

R GuenterDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
T AwedaDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL.
D M Carmona MatosDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL; San Juan Bautista School of Medicine, Caguas, PR.
S JangDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
J WhittDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
Y Q ChengDepartment of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, TX.
X M LiuDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL.
H ChenDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
S E LapiDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL.
R Jaskula-SztulDepartment of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL. Electronic address: sztul@uab.edu.
University of Alabama at Birmingham · USUniversity of North Texas Health Science Center · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
UAB Center for Clinical and Translational Sciences (CCTS)TL1TR001418 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2015 to 2018
$2.1M
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training GrantT32EB023872 · NIBIB · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROGERS, JACK M, ZHANG, JIANYI · 2018 to 2022
$753k
Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapyR21CA226491 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JASKULA-SZTUL, RENATA, LIU, XIAOGUANG MARGARET · 2020 to 2021
$364k
NCATS NIH HHS TL1 TR001418NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR003096NCI NIH HHS P30 CA013148NCI NIH HHS R21 CA226491NIBIB NIH HHS T32 EB023872NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33875251
PMCPMC10166185
OpenAlexW3156196817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.